Food and Drug Administration's Resolution of Audit Recommendations, A -07-06-03086

Office of Inspector General DEPARTMENT OF HEALTH & HUMAN SERVICES L Washington, D.C. 20201 TO: Andrew C. von Eschenbach, M.D. Commissioner of Food and Drugs FROM: for Audit Services SUBJECT: Food and Drug Administration's Resolution of Audit Recommendations (A-07-06-03083) Attached is our final report examining the Food and Drug Administration's (FDA) resolution of audit recommendations. Pursuant to Office of Management and Budget Circular A-50, section 8.a(2), and other authorities, FDA is responsible for resolving Federal and non-Federal audit report recommendations related to its activities, grantees, and contractors within 6 months after formal receipt of the reports. Monthly stewardship reports that the Office of Inspector General prepares and forwards to FDA show the status of those recommendations. Our review covered the 3 14 audit recommendations identified in stewardship reports for calendar years (CY) 2003-2005. Our objectives were to determine whether FDA had (1) resolved all audit recommendations as of December 3 1,2005, and (2) resolved audit recommendations in a timely manner during CYS 2003-2005. As of December 3 1,2005, FDA had not resolved eight audit recommendations, all of which were past due for resolution. Additionally, during CYs 2003-2005, FDA resolved 306 of the 3 14 audit recommendations, but it did not resolve 287 of these recommendations within the required 6-month period. FDA did not resolve all audit ...